AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Noblinac 200mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Biofield Pharma

Salt Composition

Aceclofenac (200mg)

Overview Noblinac 200mg Tablet SR

Nubliva 200mg Extended-Release Tablets provide pain relief. This medication reduces pain and inflammation associated with conditions such as rheumatoid arthritis, ankylosing spondylitis, and osteoarthritis. Always follow your physician's instructions regarding dosage and duration. Administer with food or milk to minimize stomach irritation. Consistent, timely use enhances efficacy. Continue taking the medication as directed until your doctor advises otherwise. Common side effects include nausea, vomiting, indigestion, and abdominal discomfort. Dizziness, drowsiness, or blurred vision may also occur. For prolonged treatment, your doctor may monitor kidney and liver function, along with blood counts. Extended use carries a risk of serious complications, including gastrointestinal bleeding and kidney damage. Nubliva 200mg Extended-Release Tablets are contraindicated during pregnancy and breastfeeding.

Uses of Noblinac 200mg Tablet SR

Analgesia

Major Benefits of Noblinac 200mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Noblinac 200mg Tablet SR with a meal.

Common Side effects of Noblinac 200mg Tablet SR:

  • Vomiting
  • Stomach pain/epigastric pain
  • Nausea
  • Indigestion
  • Diarrhea
  • Heartburn
  • Loss of appetite

How to use Noblinac 200mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Noblinac 200mg Sustained-Release Tablets should be administered with a meal.

How Noblinac 200mg Tablet SR works:

Each Noblinac 200mg extended-release tablet contains a non-steroidal anti-inflammatory drug (NSAID) that inhibits the production of inflammatory mediators responsible for pain and associated swelling and redness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Noblinac 200mg Tablet SR and alcohol is not advised due to safety concerns.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Noblinac 200mg Sustained-Release Tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Seek medical advice before taking this medication.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Data on the compatibility of Noblinac 200mg sustained-release tablets with breastfeeding is currently lacking. Seek medical advice from your physician.

DrivingDrivingUNSAFE

Taking a Noblinac 200mg sustained-release tablet might reduce awareness, impair vision, or cause drowsiness and dizziness. Driving should be avoided if these effects are experienced.

KidneyKidneyCAUTION

Exercise caution when administering Noblinac 200mg sustained-release tablets to individuals with impaired renal function; dosage modification may be necessary. A physician's consultation is advised. Noblinac 200mg sustained-release tablets are contraindicated in patients exhibiting severe kidney disease.

LiverLiverCAUTION

Exercise caution when prescribing Noblinac 200mg SR tablets to individuals with hepatic impairment; dosage modification may be necessary. Consult a physician before administering. Noblinac 200mg SR tablets are contraindicated in patients exhibiting severe liver dysfunction. Consistent monitoring of liver function is recommended throughout the treatment period.

What if you forget to take Noblinac 200mg Tablet SR :

Should you forget to take a Noblinac 200mg Tablet SR, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Noblinac 200mg Tablet SR

LabelValue
Type of Compound Benzene dichloride compounds
Potential for Dependence None.
Type of Medication Pain relievers
Mechanism of Action Nonsteroidal anti-inflammatory drugs (NSAIDs) that non-selectively inhibit cyclooxygenase-1 and -2 enzymes (acetic acid derivatives).

FAQs on Noblinac 200mg Tablet SR

A single 200mg slow-release Noblinac tablet effectively manages pain and inflammation. This medication offers relief from diverse sources of pain, including sprains, strains, and other trauma. It also proves beneficial in treating various arthritic conditions, gout, and post-surgical pain and inflammation.
Using Noblinac 200mg SR tablets as prescribed by your physician is safe. Adhere strictly to the recommended dosage and schedule; avoid missed doses. Closely observe your doctor's instructions and report any concerning side effects.
Noblinac 200mg sustained-release tablets do not produce euphoric effects. They are not associated with misuse or addictive properties, neither physical nor psychological. Nevertheless, seek medical advice if experiencing adverse effects.
Prolonged administration and substantial dosages of Noblinac 200mg Tablet SR can induce renal complications, including proteinuria, hematuria, and dysuria. Individuals with a history of, or existing, cardiac insufficiency, compromised renal function, and hypertension are predisposed to these renal adverse effects. This risk is heightened in patients concurrently using diuretics or other nephrotoxic medications. Furthermore, patients aged 65 and older, or those experiencing dehydration, are also at increased risk of Noblinac 200mg Tablet SR-induced nephrotoxicity. Consequently, regular assessment of kidney function is advised for these patient populations.
Should you miss a dose of Noblinac 200mg Tablet SR, administer it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and proceed with your regular dosing schedule. Avoid doubling the dose to compensate for the missed one, as this could heighten the risk of adverse reactions.
Prolonged-release Noblinac 200mg tablets may induce drowsiness, dizziness, fatigue, and visual impairment in some individuals. These side effects are infrequent and not universally experienced. Refrain from driving or operating complex equipment if such symptoms occur.
Using Noblinac 200mg Tablet SR elevates the risk of heart attack or stroke, particularly with higher doses and prolonged use. This medication may also induce stomach and intestinal ulcers, bleeding, or perforation, potentially fatal and without prior warning at any point during treatment. Seek immediate medical attention should any such complications arise.
Avoid Noblinac 200mg Tablet SR during the final trimester of pregnancy due to potential harm to the developing fetus. This medication may also precipitate premature labor. Therefore, its use should also be avoided during the first six months of pregnancy. Prescription for pregnant individuals should only occur when the potential benefits demonstrably exceed the inherent risks. Always seek medical advice before using this medication if you are pregnant.
Consistent use of Noblinac 200mg sustained-release tablets, as prescribed, is crucial for efficacy. Discontinuing treatment prematurely, even with symptom improvement, may lead to recurrence or exacerbation.
Noblinac 200mg Tablet SR
53
MRP 65
18% off